Xpiscoric aims to provide one-stop integrated preclinical development services that include biological screening, efficacy, pharmacokinetics and safety studies and IND filing. Powered by the years of experience of preclincial study of new drugs and IND filing, as well as well-knowledge of guidances for IND filing in China, the US and Australia, the team can manage projects in the areas of oncology, diabetes, inflammation and immune disease, anesthesia, pain, COPD, and others. By closely working with clients, we help on development strategy planning and optimization accordingly during the whole preclinical process, to ensure cost-efficient, rapid candidate confirmation and development.